Authors' reply

BMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7016.1369b (Published 18 November 1995) Cite this as: BMJ 1995;311:1369
  1. R H Vander Stichele,
  2. M G Bogaert
  1. General practitioner Clinical pharmacologist Heymans Institute of Pharmacology, De Pintelaan 185, 9000 Ghent, Belgium

    EDITOR,--Both Manice Stallbaumer and colleagues and Ian F Burgess point out the potential or inevitable development of resistance to broadly used pediculicides, which makes extrapolation of results of studies performed in one country to another country hazardous. Indeed, since we completed our manuscript reports of resistance to permethrin have been published.1 2

    We agree that a strategy for containing the pandemic of head lice should be based on the use of several active ingredients of proved efficacy. Hence we deplore …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription